|
End-of-day quote
Bulgaria S.E.
10/11/2026
|
5-day change | 1st Jan Change | ||
| 3.300 EUR | +1.54% |
|
-0.30% | +131.65% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.3B 1.98B 1.78B 1.64B 1.49B 2.81B 186B 2.89B 19.61B 7.81B 99.52B 7.44B 7.28B 315B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.84B 2.31B 2.07B 1.91B 1.73B 3.28B 216B 3.37B 22.82B 9.09B 116B 8.66B 8.47B 366B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +1.54% | ||
| 1 week | -0.30% | ||
| Current month | -1.79% | ||
| 1 month | +25.95% | ||
| 3 months | +72.77% | ||
| 6 months | +76.94% | ||
| Current year | +131.65% |
| 1 week | 3.23 |  | 3.39 |
| 1 month | 2.58 | | 3.56 |
| Current year | 1.41 | | 3.56 |
| 1 year | 1.34 | | 3.56 |
| 3 years | 0.94 | | 3.56 |
| 5 years | 0.68 | | 3.56 |
| 10 years | 0.41 | | 3.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/9/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/9/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.54% | -0.30% | +139.05% | +169.66% | 1.96B | |
| -0.37% | +6.34% | -30.68% | +11.81% | 17.49B | |
| -0.34% | +7.05% | -9.16% | +14.83% | 7.15B | |
| -0.66% | +3.58% | -8.93% | +3.26% | 6.97B | |
| -1.64% | +1.69% | -47.92% | -37.53% | 6.28B | |
| -20.55% | -1.88% | -32.77% | -44.41% | 4.69B | |
| -3.12% | -10.28% | -0.04% | -22.29% | 4.6B | |
| -1.27% | -3.06% | +8.74% | -20.16% | 3.5B | |
| +0.15% | +2.76% | -22.93% | +31.86% | 3.24B | |
| +0.14% | +2.54% | -16.23% | -19.54% | 3.21B | |
| Average | -2.63% | +3.15% | -2.09% | +8.75% | 6B | |
| Weighted average by Cap. | -2.35% | +4.95% | -15.94% | +1.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.15B 1.06B 964M 1.83B 120B 1.88B 12.72B 5.07B 64.55B 4.82B 4.72B 204B | 2.63B 1.58B 1.42B 1.31B 1.19B 2.25B 148B 2.31B 15.65B 6.23B 79.43B 5.93B 5.81B 251B |
| Net income | 77.85M 46.75M 41.93M 38.64M 35.09M 66.42M 4.38B 68.27M 463M 184M 2.35B 175M 172M 7.42B | 134M 80.19M 71.92M 66.28M 60.19M 114M 7.52B 117M 794M 316M 4.03B 301M 295M 12.73B |
| Net Debt | 444M 267M 239M 220M 200M 379M 25.01B 390M 2.64B 1.05B 13.4B 1B 980M 42.36B | 541M 325M 292M 269M 244M 462M 30.48B 475M 3.22B 1.28B 16.33B 1.22B 1.19B 51.62B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | €3.300 | +1.54% | 14,406 |
| 09/11/26 | €3.250 | -2.40% | 20,721 |
| 06/11/26 | €3.330 | +0.91% | 16,302 |
| 05/11/26 | €3.300 | +0.92% | 10,111 |
| 04/11/26 | €3.270 | -1.21% | 18,983 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
